Purple Biotech (PPBT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.65M
Last updated: Nov 17, 2026 at 11:03 AM ET
Purple Biotech (PPBT) Stock Forecast
Analysts expect Purple Biotech (PPBT) to earn -$5.73 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.01.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$5.73
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$1.01
- EPS consensus
- Fiscal year ending Dec 31, 2028
- -$0.15
- EPS consensus, revenue $6.50M
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$5.73 | -$5.73 to -$5.73 | 1 | N/A | N/A | 1 |
| Dec 31, 2027 | -$1.01 | -$1.01 to -$1.01 | 1 | N/A | N/A | 1 |
| Dec 31, 2028 | -$0.15 | -$0.15 to -$0.15 | 1 | $6.50M | $6.50M to $6.50M | 1 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$1.65.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$5.73 | -$5.31 | -$5.31 | -$5.31 | -$1.65 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.01 | -$0.88 | -$0.88 | -$0.88 | -$0.64 | N/A |
Frequently Asked Questions About PPBT
What is the PPBT stock forecast?
Consensus analyst estimates put Purple Biotech's EPS at -$5.73 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from PPBT next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$5.73, with estimates from -$5.73 to -$5.73 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.01, with estimates from -$1.01 to -$1.01 from 1 analyst.
What revenue do analysts expect from Purple Biotech next year?
For the fiscal year ending Dec 31, 2028, the consensus revenue estimate is $6.50M, with estimates from $6.50M to $6.50M.
How many analysts cover PPBT?
1 analyst estimates EPS for Purple Biotech for the fiscal year ending Dec 31, 2026.
PPBT pages: Overview, Earnings, Forecast, Financials, Competitors